In trials, the antipsychotic drug brexpiprazole (Rexulti) failed to provide a clinically meaningful benefit and increased the risk of death. Yet the US Food and Drug Administration (FDA) has fast tracked its approval, making Rexulti the first antipsychotic for treating agitation in elderly patients with dementia.
At a cost of around $1,400 a month Rexulti's makers, Otsuka and Lundbeck, are forecasting an additional $1 billion in annual sales, but there are serious questions about the harm-benefit balance of this drug, writes investigative journalist Robert Whitaker inThe decision may also reverse years of effort by the US Centers for Medicare and Medicaid Services to reduce the widespread off-label use of antipsychotics in residential care homes.
"The small benefits do not outweigh serious safety concerns," Public Citizen health researcher Nina Zeldes told the FDA's Advisory Committee prior to the approval."Like other antipsychotics, this is a drug that can kill patients without providing a meaningful benefit." The chair of the advisory committee, Rajesh Narendran, did not respond to multiple requests for an interview to answer questions raised by this approval, while a spokesperson for the FDA's Center for Drug Evaluation and Research stated that"due to conflicting schedules and competing priorities," the FDA would be unable to respond.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Search for paddleboarder off Orkney coast 'false alarm' as helicopter stood downThe Coastguard launched a search involving two water rescue teams and a helicopter after receiving a call raising concerns at around 9pm on Wednesday.
Lire la suite »
Turmoil at Zhongzhi sparks alarm over China’s $3tn shadow financing industry\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
Lire la suite »
Turmoil at Zhongzhi sparks alarm over China’s $3tn shadow finance sector\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
Lire la suite »
Donald Trump’s racketeering indictment is the most sweeping yetA Georgia prosecutor lays out her claims of a criminal enterprise
Lire la suite »
Global oil demand hits record and may rise further, says International Energy AgencyConsumption data shows global efforts to cut carbon emissions are yet to have significant impact
Lire la suite »
Man arrested in Northern Ireland police data leakPlus laptop and radio with yet more officers details reportedly nicked from car
Lire la suite »